Indications and uses
Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Urinary Pain Relief - YYBA CORP
- Manufacturer
- YYBA CORP
- Effective date
- 2026-04-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:56:28
Label at a glance#
ProductUrinary Pain Relief
Active ingredientPHENAZOPYRIDINE HYDROCHLORIDE
Label structure10 sections
Dosage and administration
Adults and children 12 years and older: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor Children under 12: Do not use without consulting a doctor
Storage and handling
This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests This product may stain contact lenses and other items if handled after touching tablets. Store at room temperature (59°-86°F) in a dry place and protect from light
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient (in each tablet)
Phenazopyridine Hydrochloride 99.5 mg
Purpose
Urinary tract analgesic
Uses
Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Warnings
Do not exceed recommended dosage.
Ask a doctor before use if you have
- kidney disease
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to Phenazopyridine Hydrochloride
Do not use
if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician
When using this product
- stomach upset may occur, taking this product with or after meals may reduce stomach upset
- your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
Stop use and ask a doctor if
- your symptoms last for more than 2 days
- you suspect you are having an adverse reaction to the medication
- long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.
If pregnant or breastfeeding,
ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.
Keep out of reach of children.
In case of an overdose, get medical help or contact a Poison Control Center call (1-800-222-1222) right away.
Directions
Adults and children 12 years and older:Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor
Children under 12:Do not use without consulting a doctor
Other information
- This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
- This product may stain contact lenses and other items if handled after touching tablets.
- Store at room temperature (59°-86°F) in a dry place and protect from light
Inactive ingredients
colloidal silicone dioxide, croscarmellose sodium, hydroxypropyl methylcellulose, magnesium stearate, maize (corn) starch, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch
Questions?
call toll-free 1-866-933-6337
PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0373581000630 | GTIN-13: 0373581000630 EAN-13: 0373581000630 GTIN-12: 373581000630 UPC-A: 373581000630 GTIN storage (14 digits): 00373581000630 | label.jpg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73581-919-12 | Urinary Pain Relief | 120 in 1 BOTTLE | TABLET | 120 | 1 | |
| 73581-919-36 | Urinary Pain Relief | 36 in 1 BOTTLE | TABLET | 36 | 1 | |
| 73581-919-72 | Urinary Pain Relief | 72 in 1 BOTTLE | TABLET | 72 | 1 |
Products#
Every source-derived product name is available through these pages.
- Urinary Pain Relief
- Phenazopyridine Hydrochloride
- MAGNESIUM STEARATE
- SILICON DIOXIDE
- HYPROMELLOSE, UNSPECIFIED
- STARCH, CORN
- POLYETHYLENE GLYCOL 400
- CELLULOSE, MICROCRYSTALLINE
- POVIDONE K30
- CROSCARMELLOSE SODIUM
- PHENAZOPYRIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 73581-919 | 73581-919-72, 73581-919-36, 73581-919-12 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| PHENAZOPYRIDINE HYDROCHLORIDE | 0EWG668W17 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | YYBA CORP | f2d9f6aa-081e-4723-9417-5191b31d2952 | 2026-04-01 | Warnings | 73581-919-36 73581-919-12 73581-919-72 73581-919 73581091912 73581091972 73581091936 5137d15a-1390-d5f1-e063-6394a90aabfd f2d9f6aa-081e-4723-9417-5191b31d2952 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.